Mari O. Brady
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mari O. Brady has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Amy E. Neely
Department of Molecular Biosciences, Northwestern University, Evanston, USA
1 shared publicationDaniel B. Leon
Department of Molecular Biosciences, Northwestern University, Evanston, USA
1 shared publication- Deborah Rodriguez
Department of Molecular Biosciences, Northwestern University, Evanston, USA
1 shared publication Junghun Kweon
Department of Molecular Biosciences, Northwestern University, Evanston, USA
1 shared publicationLaura A. Blumensaadt
Department of Molecular Biosciences, Northwestern University, Evanston, USA
1 shared publicationMadison P. McReynolds
Department of Molecular Biosciences, Northwestern University, Evanston, USA
1 shared publication
Latest Publications
- Open Access
- 29 July 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-18
CDK9 activity switch associated with AFF1 and HEXIM1 controls differentiation initiation from epidermal progenitors
Progenitors in epithelial tissues, such as human skin epidermis, continuously make fate decisions between self-renewal and differentiation. Here we show that the Super Elongation Complex (SEC) controls progenitor fate decisions by directly suppressing a group of “rapid response” genes, which feature high enrichment of paused Pol II in the progenitor state and robust Pol II elongation in differentiation. SEC’s repressive role is dependent on the AFF1 scaffold, but not AFF4. In the progenitor state, AFF1-SEC associates with the HEXIM1-containing inactive CDK9 to suppress these rapid-response genes. A key rapid-response SEC target is ATF3, which promotes the upregulation of differentiation-activating transcription factors (GRHL3, OVOL1, PRDM1, ZNF750) to advance terminal differentiation. SEC peptidomimetic inhibitors or PKC signaling activates CDK9 and rapidly induces these transcription factors within hours in keratinocytes. Thus, our data suggest that the activity switch of SEC-associated CDK9 underlies the initial processes bifurcating progenitor fates between self-renewal and differentiation.
- 29 July 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-18
Open AccessCDK9 activity switch associated with AFF1 and HEXIM1 controls differentiation initiation from epidermal progenitors
Progenitors in epithelial tissues, such as human skin epidermis, continuously make fate decisions between self-renewal and differentiation. Here we show that the Super Elongation Complex (SEC) controls progenitor fate decisions by directly suppressing a group of “rapid response” genes, which feature high enrichment of paused Pol II in the progenitor state and robust Pol II elongation in differentiation. SEC’s repressive role is dependent on the AFF1 scaffold, but not AFF4. In the progenitor state, AFF1-SEC associates with the HEXIM1-containing inactive CDK9 to suppress these rapid-response genes. A key rapid-response SEC target is ATF3, which promotes the upregulation of differentiation-activating transcription factors (GRHL3, OVOL1, PRDM1, ZNF750) to advance terminal differentiation. SEC peptidomimetic inhibitors or PKC signaling activates CDK9 and rapidly induces these transcription factors within hours in keratinocytes. Thus, our data suggest that the activity switch of SEC-associated CDK9 underlies the initial processes bifurcating progenitor fates between self-renewal and differentiation.